FDA STATE_REFERRAL_LETTER - Barclay, Luke, & Pillai Specialty Pharmacy, PLLC - November 28, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Barclay, Luke, & Pillai Specialty Pharmacy, PLLC

Record Details

This STATE REFERRAL LETTER record concerns Barclay, Luke, & Pillai Specialty Pharmacy, PLLC, with an inspection on November 28, 2022, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
Inspection Date: November 28, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Dave Wuest
Rumany C. Penn (Compliance Officer)
Sean M. Barclay

Open in Dashboard

ID · 82530ed6-9f46-4c08-bcbb-725fd6eee63b

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A

Full citation text and observation details available on the Dashboard.